A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease

Inflammation and oxidative stress play a key role in the pathophysiology of advanced chronic liver disease (ACLD) and portal hypertension (PH). Considering the current lack of effective treatments, we evaluated an anti-inflammatory and antioxidant nutraceutical rich in docosahexaenoic acid (DHA) as...

Full description

Bibliographic Details
Main Authors: Zoe Boyer-Diaz, Joan Carles Domingo, Estefanía De Gregorio, Nicolò Manicardi, Peio Aristu-Zabalza, Begoña Cordobilla, Laia Abad-Jordà, Martí Ortega-Ribera, Anabel Fernández-Iglesias, Montserrat Marí, Jaime Bosch, Jordi Gracia-Sancho
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Nutrients
Subjects:
dha
omega-3
liver fibrosis
liver cirrhosis
hepatic hemodynamics
Online Access:https://www.mdpi.com/2072-6643/11/10/2358

Internet

https://www.mdpi.com/2072-6643/11/10/2358

Similar Items